This inventor holds 1 USPTO granted patent. Top assignee: 3M Innovative Properties Company. Active years: 1983.
Company Filing History:
Years Active: 1983
Title: William E Barnett: Innovator in Diagnostic Technologies
Introduction
William E Barnett is a notable inventor based in Saint Paul, MN (US). He has made significant contributions to the field of diagnostic technologies, particularly in the area of blood clot detection. His innovative work has led to the development of a unique class of compounds that enhance medical diagnostics.
Latest Patents
Barnett holds a patent for "Diagnostic radio-labeled polysaccharide derivatives." This invention introduces a novel class of chelated radio-labeled polysaccharide derivatives that are useful for diagnosing formed and forming blood clots in the vascular system. The patent describes intermediate metal-binding compounds that consist of a water-soluble polysaccharide moiety with an average of at least 0.25 anionic groups per monosaccharide unit, along with at least one chelating group derived from amino acids, substituted cyclic acid anhydrides, or carbon disulfide. The intermediate compound is then reacted with a radioactive tracer metal compound, providing a valuable tool for medical diagnostics.
Career Highlights
William E Barnett is associated with 3M Innovative Properties Company, where he has been able to apply his expertise in developing innovative diagnostic solutions. His work at 3M has allowed him to contribute to advancements in medical technology, particularly in the area of vascular health.
Collaborations
Throughout his career, Barnett has collaborated with esteemed colleagues, including Dean S Milbrath and Richard H Ferber. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
William E Barnett's contributions to diagnostic technologies exemplify the impact of innovation in healthcare. His patented work on radio-labeled polysaccharide derivatives showcases his commitment to improving medical diagnostics and patient care.
